Table 1.
Patient demographics.
| GROUP |
|||||
|---|---|---|---|---|---|
|
CHARACTERISTIC |
DDAVP |
CONTROL |
|||
| Number (N) = 65 | Mean ± SD(median when specified) | Range | Mean ± SD(median when specified) | Range | p-value |
| AGE (years) | 54.5 (IQR 47–66)Median 54.5 (IQR 47–66) | 30–84 | 54 (IQR 45–66.5) | 14–87 | 0.79 |
| Gender | 43 men (66%)22 women (34%) | 42 men (64.6%)23 women (35.4%) | 0.85 | ||
| KIDNEY | 36 native (55.4%) | 36 native (55.4%) | 1 | ||
| NUMBER OF GLOMERULI | Mean 10.74 ± 7.8Median 10 | 0–41 | Mean 11.27 ± 7.4Median 10 | 0–34 | 0.7 |
| PLATELET COUNT (×109/L) | 201.049 ± 71.11 | 75.3–413 | 225.215 ± 72.9 | 109–483 | 0.018 |
| Col-ADP time (s) | 141 ± 52 | 0–126 | 86 ± 15 | 0.001 | |
| Col-Epi time (s) | 184 ± 66 | 0–170 | 116 ± 20 | 0.001 | |
| Hb pre-biopsy (g/L) | 110 ± 22 | 81–170 | 128 ± 23 | 87–173 | 0.001 |
| Hb post-biopsy (g/L) | 105 ± 22 | 125–161 | 125 ± 21 | 83–176 | 0.001 |
| eGFR (MDRD4, mL/minute/1.73 m2) | Mean 27.25 ± 22.28Median 18 (IQR 12–37) | 2.1–102 | Mean 50.13 ± 37.58Median 33 (IQR 24–65) | 7–174 | 0.001 |
| BPs pre-biopsy (mmHg) | 143 ± 32 | 100–212 | 153 ± 22 | 109–210 | NS |
| BPd pre-biopsy (mmHg) | 84 ± 11 | 60–99 | 86 ± 10 | 61–110 | NS |
| Sodium pre-biopsy (mmol/L) | 138.12 ± 3.69 | 128–145 | 139 ± 3.1 | 131–147 | 0.77 |
| Sodium post-biopsy (mmol/L) | 136.62 ± 3.98 | 124–144 | 138.9 ± 3.1 | 130–146 | 0.028 |
DDAVP: 1-deamino8-D-arginine vasopressin; SD, standard deviation; Col-ADP: collagen-adenosine diphosphate; Col-Epi: collagen-epinephrine; Hb: haemoglobin; eGFR: estimated glomerular filtration rate; BPs: systolic blood pressure; BPd: diastolic blood pressure.